Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 5, 2006, Pages 1761-1769

  Hinney, Anke ^a   Bettecken, Thomas ^b,f   Tarnow, Patrick ^c   Brumm, Harald ^c   Reichwald, Kathrin ^a,d   Lichtner, Peter ^b   Scherag, André ^e   Nguyen, Thuy Trang ^e   Schlumberger, Pia ^e   Rief, Winfried ^e   Vollmert, Caren ^b   Illig, Thomas ^b   Wichmann, H Erich ^b   Schäfer, Helmut ^e   Platzer, Matthias ^d   Biebermann, Heike ^c   Meitinger, Thomas ^b   Hebebrand, Johannes ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d FRITZ LIPMANN INSTITUTE   (Germany)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MELANOCORTIN 4 RECEPTOR;

ADULT; AGED; ARTICLE; BODY MASS; CAPILLARY ELECTROPHORESIS; FEMALE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; NONSENSE MUTATION; OBESITY; PREVALENCE; PRIORITY JOURNAL; SPECTRUM; STATISTICAL ANALYSIS;

ADULT; AGED; AGING; BODY MASS INDEX; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GENE FREQUENCY; GENETIC SCREENING; GERMANY; HUMANS; MALE; MIDDLE AGED; MUTATION; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, MELANOCORTIN, TYPE 4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33646423288     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2056     Document Type: Article

References (43)

1. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S 2003 Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 348:1085-1095
2. Farooqi IS, O'Rahilly S 2005 Monogenic obesity in humans. Annu Rev Med 56:443-458
3. Cone RD 2005 Anatomy and regulation of the central melanocortin system. Nat Neurosci 8:571-578
4. Herpertz S, Siffert W, Hebebrand J 2003 Binge eating as a phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 349:606-609
5. Potoczna N, Branson R, Kral JG, Piec G, Steffen R, Ricklin T, Hoehe MR, Lentes KU, Horber FF 2004 Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity. J Gastrointest Surg 8:971-982
6. Buono P, Pasanisi F, Nardelli C, Ieno L, Capone S, Liguori R, Finelli C, Oriani G, Contaldo F, Sacchetti L 2005 Six novel mutations in the proopiomelanocortin and melanocortin receptor 4 genes in severely obese adults living in southern Italy. Clin Chem 51:1358-1364
7. Tao YX 2005 Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Mol Cell Endocrinol 239:1-14
8. Zakel UA, Wudy SA, Heinzel-Gutenbrunner M, Gorg T, Schafer H, Gortner L, Blum WF, Hebebrand J, Hinney A 2005 [Prevalence of melanocortin 4 receptor (MC4R) mutations and polymorphisms in consecutively ascertained obese children and adolescents from a pediatric health care utilization population]. Klin Padiatr 217:244-249 (German)
9. Jacobson P, Ukkola O, Rankinen T, Snyder EE, Leon AS, Rao DC, Skinner JS, Wilmore JH, Lonn L, Cowan Jr GS, Sjostrom L, Bouchard C 2002 Melanocortin 4 receptor sequence variations are seldom a cause of human obesity: the Swedish Obese Subjects, the HERITAGE Family Study, and a Memphis cohort. J Clin Endocrinol Metab 87:4442-4446
10. Marti A, Corbalan MS, Forga L, Martinez JA, Hinney A, Hebebrand J 2003 A novel nonsense mutation in the melanocortin-4 receptor associated with obesity in a Spanish population. Int J Obes Relat Metab Disord 27:385-388
11. Hinney A, Hohmann S, Geller F, Vogel C, Hess C, Wermter AK, Brokamp B, Goldschmidt H, Siegfried W, Remschmidt H, Schafer H, Gudermann T, Hebebrand J 2003 Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J Clin Endocrinol Metab 88:4258-4267
12. Tao YX, Segaloff DL 2005 Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects. J Clin Endocrinol Metab 90:5632-5638
13. Nijenhuis WA, Garner KM, VanRozen RJ, Adan RA 2003 Poor cell surface expression of human melanocortin-4 receptor mutations associated with obesity. J Biol Chem 278:22939-22945
14. Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G, Cheetham T, O'Rahilly S 2000 Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 106:271-279
15. Dempfle A, Hinney A, Heinzel-Gutenbrunner M, Raab M, Geller F, Gudermann T, Schafer H, Hebebrand J 2004 Large quantitative effect of melanocortin-4 receptor gene mutations on body mass index. J Med Genet 10:795-800
16. Sina M, Hinney A, Ziegler A, Neupert T, Mayer H, Siegfried W, Blum WF, Remschmidt H, Hebebrand J 1999 Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene. Am J Hum Genet 65:1501-1507
17. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P 2000 Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 106:253-262
18. Valli-Jaakola K, Lipsanen-Nyman M, Oksanen L, Hollenberg AN, Kontula K, Bjorbaek C, Schalin-Jantti C 2004 Identification and characterization of melanocortin-4 receptor gene mutations in morbidly obese Finnish children and adults. J Clin Endocrinol Metab 89:940-945
19. Holle R, Happich M, Lowel H, Wichmann HE, MONICA/KORA Study Group 2005 KORA: a research platform for population based health research. Gesundheitswesen 67(Suppl 1):S19-S25
20. Mogensen J, Bahl A, Kubo T, Elanko N, Taylor R, McKenna WJ 2003 Comparison of fluorescent SSCP and denaturing HPLC analysis with direct sequencing for mutation screening in hypertrophic cardiomyopathy. J Med Genet 40:e59
21. Ewing B, Green P 1998 Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res 8:186-194
22. Bonfield JK, Smith K, Staden R 1995 A new DNA sequence assembly program. Nucleic Acids Res 23:4992-4999
23. Biebermann H, Schöneberg T, Krude H, Schultz G, Gudermann T, Grüters A 1997 Mutations of the human thyrotropin gene causing thyroid hypoplasia and persistent congenital hypothyroidism. J Clin Endocrinol Metab 82:3471-3480
24. Biebermann H, Krude H, Elsner A, Chubanov V, Gudermann T, Gruters A 2003 Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. Diabetes 52:2984-2988
25. Schulz A, Grosse R, Schultz G, Gudermann T, Schöneberg T 2000 Structural implication for receptor oligomerization from functional reconstitution studies of mutant V2 vasopressin receptors. J Biol Chem 275:2381-2389
26. Clopper CJ, Pearson E 1934 The use of confidence or fiducial limits illustrated in the case of binomial. Biometrika 26:404-413
27. Larsen LH, Echwald SM, Sorensen TI, Andersen T, Wulff BS, Pedersen O 2005 Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity. J Clin Endocrinol Metab 90:219-224
28. Lefkowitz RJ, Cotecchia S, Samama P, Costa T 1993 Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14:303-307
29. Lubrano-Berthelier C, Durand E, Dubern B, Shapiro A, Dazin P, Weill J, Ferron C, Froguel P, Vaisse C 2003 Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum Mol Genet 12:145-153
30. Geller F, Reichwald K, Dempfle A, Illig T, Vollmert C, Herpertz S, Siffert W, Platzer M, Hess C, Gudermann T, Biebermann H, Wichmann HE, Schafer H, Hinney A, Hebebrand J 2004 Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am J Hum Genet 74:572-581
31. Heid IM, Vollmert C, Hinney A, Doring A, Geller F, Lowel H, Wichmann HE, Illig T, Hebebrand J, Kronenberg F, KORA Group 2005 Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys. J Med Genet 42:e21
32. Hinney A, Schmidt A, Nottebom K, Heibult O, Becker I, Ziegler A, Gerber G, Sina M, Gorg T, Mayer H, Siegfried W, Fichter M, Remschmidt H, Hebebrand J 1999 Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 84:1483-1486
33. Hebebrand J, Friedel S, Schauble N, Geller F, Hinney A 2003 Perspectives: molecular genetic research in human obesity. Obes Rev 4:139-146
34. Hirschhorn JN, Altshuler D 2002 Once and again-issues surrounding replication in genetic association studies. J Clin Endocrinol Metab 87:4438-4441
35. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH 2004 Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305:869-872
36. Begg CB 2002 On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 94:1221-1226
37. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Birch JM, Lindblom A, Stoppa-Lyonnet D, Bignon Y, Borg A, Hamann U, Haites N, Scott RJ, Maugard CM, Vasen H, Seitz S, Cannon-Albright LA, Schofield A, Zelada-Hedman M, Breast Cancer Linkage Consortium 1998 Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676-689
38. Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C, Ozcelik H, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R, Honeyford J, Liede A, Glendon G, Brunet JS, Narod S 1999 Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91:1241-1247
39. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA 1997 The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401-1408
40. Srinivasan S, Lubrano-Berthelier C, Govaerts C, Picard F, Santiago P, Conklin BR, Vaisse C 2004 Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. J Clin Invest 114:1158-1164
41. Santini F, Maffei M, Ceccarini G, Pelosini C, Scartabelli G, Rosellini V, Chiellini C, Marsili A, Lisi S, Tonacchera M, Agretti P, Chiovato L, Mammoli C, Vitti P, Pinchera A 2004 Genetic screening for melanocortin-4 receptor mutations in a cohort of Italian obese patients: description and functional characterization of a novel mutation. J Clin Endocrinol Metab 89:904 -908
42. Gu W, Tu Z, Kleyn PW, Kissebah A, Duprat L, Lee J, Chin W, Maruti S, Deng N, Fisher SL, Franco LS, Burn P, Yagaloff KA, Nathan J, Heymsfield S, Albu J, Pi-Sunyer FX, Allison DB 1999 Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes 48:635-639
43. Tarnow P, Schoneberg T, Krude H, Gruters A, Biebermann H 2003 Mutationally induced disulfide bond formation within the third extracellular loop causes melanocortin 4 receptor inactivation in patients with obesity. J Biol Chem 278:48666-48673